Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Vaccine|March 28, 2018
Status of HPV vaccine introduction and barriers to country uptakeK E Gallagher, D S LaMontagne, D Watson-JonesSexually Transmitted Infections|October 2, 2004
Establishing the National Chlamydia Screening Programme in England: results from the first full year of screeningD S LaMontagne, K A Fenton, S Randall, et al.Sexually Transmitted Infections|December 8, 2006
Modelling the effectiveness of chlamydia screening in EnglandK M E Turner, E J Adams, D S Lamontagne, et al.Sexually Transmitted Infections|October 2, 2004
Modelling the healthcare costs of an opportunistic chlamydia screening programmeE J Adams, D S LaMontagne, A R Johnston, et al.African Journal of Reproductive Health|May 14, 2009
An assessment of the readiness for introduction of the HPV vaccine in UgandaR A Katahoire, J Jitta, G Kivumbi, et al.Human Vaccines & Immunotherapeutics|May 10, 2016
The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countriesN Howard, S Mounier-Jack, K E Gallagher, et al.International Journal of STD & AIDS|May 19, 2005
Using chlamydia positivity to estimate prevalence: evidence from the Chlamydia Screening Pilot in EnglandD S LaMontagne, K A Fenton, J M Pimenta, et al.Sexually Transmitted Infections|June 1, 2004
Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002A E Brown, K E Sadler, S E Tomkins, et al.Sexually Transmitted Infections|February 8, 2006
Monitoring the effectiveness of HIV and STI prevention initiatives in England, Wales, and Northern Ireland: where are we now?A E Brown, S E Tomkins, L E Logan, et al.Pageof 1